Skip to main content
. 2019 Oct 15;11(10):2473. doi: 10.3390/nu11102473

Table 2.

Pharmacokinetic parameters of five drugs (PO dosing) after the administration of a single oral dose of ABO in rats 1.

Drugs Dose (mg/kg) AUC (0-t) 2 (μg/mL×h) Tmax 3 (h) Cmax 4 (μg/mL) t1/25 (h) F% 6
Theophylline (CYP1A2)
Control group 10 52.9 ± 15.9 2.8 ± 1.3 4.8 ± 0.7 5.6 ± 1.5 86.0 ± 15.9
ABO group 73.9 ± 17.2 * 2.0 ± 0.0 7.1 ± 0.9 * 6.5 ± 1.9 124.8 ± 14.7 *
Diclofenac (CYP2C)
Control group 20 22.2 ± 7.9 1.5 ± 0.7 4.7 ± 2.2 4.1 ± 1.6 29.2 ± 8.1
ABO group 27.1 ± 8.5 1.3 ± 0.8 6.7 ± 3.0 2.5 ± 0.8 40.5 ± 12.1
Dextromethorphan (CYP2D)
Control group 25 0.40 ± 0.15 1.2 ± 0.6 0.13 ± 0.1 3.1 ± 0.5 10.0 ± 2.8
ABO group 0.78 ± 0.23 * 1.5 ± 0.6 0.22 ± 0.2 3.1 ± 0.8 18.6 ± 6.8 *
Chlorzoxazone (CYP2E1)
Control group 5 12.6 ± 2.7 1.3 ± 0.8 2.8 ± 0.6 4.1 ± 1.9 76.2 ± 11.5
ABO group 13.0 ± 2.3 1.3 ± 0.6 3.8 ± 0.9 * 2.7 ± 1.1 78.1 ± 11.3
Diltiazem (CYP3A)
Control group 40 0.24 ± 0.04 1.3 ± 0.8 0.073 ± 0.028 2.0 ± 0.7 1.3 ± 0.1
ABO group 0.45 ± 0.22 # 1.0 ± 0.8 0.131 ± 0.045 * 2.0 ± 0.8 2.2 ± 1.0

1 Drug cocktail was administered intravenously at a dose of 5–40 mg/kg BW to rats 1 h after the administration of control oil (soybean oil; 2.5 mL/kg BW) or ABO (2.5 mL/kg BW). Pharmacokinetic parameters were expressed as the mean ± SD of six rats in each group. 2 AUC: area under the plasma drug concentration curve. t = 12 h. 3 Tmax: the time at which maximum concentration is observed. 4 Cmax: values of maximal observed concentration. 5 t1/2: half-life, the time required for the amount of drug in the body to decrease by half. 6 F% = (AUCPO(0−12h)/PO dose) ×100/(AUCIV(0−12h)/IV dose). Oral bioavailability of the theophylline calculated by a computer fitting method was approximately or greater than 100%, suggesting that the theophylline was completely absorbed [30]. * Significantly different from the control group, p < 0.05. # Significantly different from the control group, p < 0.1.